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Abstract
MicroRNAs (miRNAs) play important roles in the regulation of genes associated with cancer development and progression.
By the more deeply characterization of miRNAs’ effect in cancer development, it requires a useful tool to investigate
expression and distribution of a miRNA in cancer cells and tissues. To fulfill this application demand, we developed a miRNA
in situ hybridization (MISH) approach using the 29-Fluoro modified miRNA probe in combination with enzyme-labeled
fluorescence (ELF) signal amplification approach. MISH was used to study expression of miR-375 in esophageal squamous
cell carcinoma (ESCC) cell lines and tissues using a tissue microarray (TMA) containing 300 cases. The results showed that
our MISH approach is a practical way to detect expression and distribution of a tested miRNA in both cultured cells and
archive tissue sections. MISH results also showed that miR-375 was frequently downregulated in ESCCs, which was
significantly associated with advanced clinical stage (p = 0.003) tumor metastasis (p = 0.04) and poor outcome (p = 0.04) of
ESCC. Moreover, the accuracy of MISH results could be confirmed by QRT-PCR. Our results demonstrated that MISH is a
useful and reliable tool to study miRNA expression in solid tumors. Downregulation of miR-375 can be used as a biomarker
to predict the outcome of ESCC.
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Introduction
MicroRNAs (miRNAs) are short (approximately 22 nucleotides)
non-coding RNA molecules that regulate gene expression [1].
Recently, miRNAs have been reported to be involved in the
development and progression of solid tumors including lung
cancer and esophageal squamous cell carcinoma (ESCC) [2–5].
Studies have shown that miRNAs can be used as specific
biomarkers for cancers [6,7], for example, miR-375 and miR-
146b-5p can be used to predict the prognosis of patients with
ESCC and lung cancer, respectively [5,8]. In our previous study,
miR-375 has been found to be frequently downregulated in ESCC
that is significantly associated with advanced clinical stage, tumor
metastasis and poor prognosis [5].
Currently, quantitative real-time PCR (QRT-PCR), northern
blot analysis and microarray are most frequently used assays to
determine miRNA expression levels. One major limitation of these
assays is that they cannot accurately detect miRNA expression in
individual cell. Another application limitation is that they cannot
investigate the distribution of miRNA in paraffin sections, which
are necessary for studying the correlation between clinicopatho-
logical features and the miRNA of interest, as well as mechanisms
of miRNA action in cancer cell proliferation or apoptosis [9].
Therefore, it is imperative to develop a useful and reliable tool to
investigate expression and distribution of a miRNA in cancer cells
and tissues. In the present study, we developed a miRNA in situ
hybridization (MISH) approach using the 29-Fluoro modified
miRNA (29-F RNA) probe combined with an enzyme-labeled
fluorescence (ELF) signal amplification technology. 29-F RNA has
been reported to increase melting temperature (Tm) and subse-
quently enhance the hybridization stability [10]. The MISH signal
can be effectively amplified with ELF approach. Our data
demonstrated that the MISH approach was a very reliable tool
to detect expression level and cell distribution of a given miRNA in
cancer cells and paraffin-embedded tissue sections.
Materials and Methods
Ethics Statement
ESCC tissue specimens used in this study were approved by the
Committees for Ethical Review of Research involving Human
Subjects at Zhengzhou University (Approval ID: UW 11-043).
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Written informed consents for the original human work that
produced the tissue samples were obtained.
Cell Lines and Clinical Samples
Non-small cell lung cancer cell lines ACC212102 and
SCC211441 were established by our lab [11]. ESCC cell lines
KYSE140, KYSE180 and KYSE510, were obtained from DSMZ
(Braunschweig, Germany), the German Resource Centre for
Biological Material. ESCC cell line HKESC1 was kindly provided
by Professor Srivastava (Department of Pathology, The University
of Hong Kong, Hong Kong) [12]. The cells were cultured in
DMEM with 10% FBS on glass cover slides at 37uC with 5%
CO2. When the cell confluence reached 70%–80%, they were
immediately fixed in 10% formalin for 2 hr, and subsequent ISH
was performed on the glass cover slides.
The primary ESCC tumor tissues and paired nontumorous
tissues were obtained from Linzhou Cancer Hospital (Henan,
China). No patients recruited in this study have received any
preoperative treatment.
Tissue Microarray (TMA)
A total of 300 formalin-fixed and paraffin-embedded ESCC
specimens and the corresponding normal esophageal tissues were
obtained from the archives of diagnosed ESCCs in Linzhou
Cancer Hospital (Henan, China). The TMA blocks were
constructed according to the method described previously [13].
All tissue samples used in this study were approved by the
Committees for Ethical Review of Research Involving Human
Subjects at Zhengzhou University.
MISH Probes
Oligonucleotide probes complementary to hsa-miR-146b-5p
and has-miR-375 were purchased from the Exonbio Lab
(Guangzhou, China). The probe sequences were as follows: 59-
AGCCTATGGAATTCAGTTCTCA-39 (miR-146b-5p) and 59-
TCACGCGAGCCGAACGAACAAA-39 (miR-375). These oligo-
nucleotides contain 29-fluoro-modified RNA residues (29-F RNA)
at the 3, 6, 15 and 20 base, which can increase melting
temperature (Tm) and subsequently enhance the hybridization
Figure 1. Detection of miR-146b-5p expression in lung cancer by MISH. (A) Representative images of miR-146b-5p expression in a lung
cancer cell line SCC211441. Cytoplasmic expression of miR-146b-5p could be specifically detected by 29-Fluoro modified miR-146b-5p probe but not
by the scramble control probe (1,0006magnification). Notably, expression of miR-146b-5p was not observed in one tumor cell (right panel, indicated
by an arrow). (B) MISH can be effectively used to detect miRNA expression in archive paraffin-embedded tissue sections. Overexpression of miR-146b-
5p was detected in the cancer tissue by MISH compared to the corresponding non-tumor tissue (1,0006magnification).
doi:10.1371/journal.pone.0053582.g001
miR-375 in ESCC
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stability. Both 59 and 39 ends were labeled by digoxin (DIG). A
scramble probe 59-AGTCTATGGTATTCAGTACTCA-39 was
used as a control.
In Situ Hybridization
Approximately 5–10 mm thick sections from tissues or tissue
microarray blocks were deparaffinized, dehydrated and subse-
quently immersed in 0.2 N HCl for 20 min. Slides were then
immersed in 0.5% Tween (PBS) solution, and the tissues were
fixed in 10% neutral-buffered formalin. Proteinase K (working
solution: 200 mg/ml in PBS) digestion was used to treat fixed
tissues at 37uC for 5 min, but culture samples on glass cover slides
were treated only with 0.1% Triton-100/PBS. After digestion,
slides were immersed in RNase-free water for 3 min and air dried.
The slides were then prehybridized in hybridization buffer (65%
formamide, 56SSC, 1% Tween-20, 100 mg/ml yeast RNA) at
37uC for 2 hr, followed by the hybridization with probe at 37uC
for 24 hr. After hybridization, slides were washed in 26SSC with
0.5% Tween-20 two stringent times for 5 min at room temper-
ature.
MISH Detection
Enzyme-labeled fluorescence (ELF) signal amplification kit
(Invitrogen, San Diego, CA) was used to amplify and detect
MISH signals according to the manufacturer’s protocol [14]. The
kit uses substrate cleavage by a phosphatase to produce a green
fluorescence at the site of enzymatic activity. The MISH signal is
up to 40 times brighter compared to probes directly labeled with
fluorophores. The slides were counterstained with Hoechst 33342
(1 mg/ml). Images of miRNA signals in cells were captured by an
Olympus BX51 fluorescence microscope. To make the MISH
Figure 2. Detection of miR-375 expression in ESCC by MISH. (A) Expression of miR-375 in ESCC cell line KYSE-510 could be specifically
detected by miR-375 probe but not by the scramble control probe (1,0006magnification). Notably, the expression level of miR-375 was various
among tumor cells. (B) Representative images of miR-375 expression in a paired archive tissue sections (ESCC tumor and its corresponding non-
tumor tissues) detected by MISH. The result showed that expression of miR-375 was downregulated in the cancer tissue compared to its
corresponding non-tumor tissues (2006magnification).
doi:10.1371/journal.pone.0053582.g002
miR-375 in ESCC
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signals comparable among images, the exposure time for all image
captured in the present study was 0.1 seconds.
Quantitative Real-Time PCR of miRNA
Total RNA was extracted from cultured cells using the TRIzol
reagent (Invitrogen, Carlsbad, CA). miRNAs from paraffin-
embedded ESCC specimens were extracted using the miRNeasy
FFPE kit (Qiagen, Valencia, CA). Advantage RT-PCR Kit
(Clontech Laboratories, Inc., Mountain View, CA) was used to
synthesize the first strand complementary DNA. qPCR was
performed with primers for miR-375 and 18 s as described
previously with SYBR in 7900 HT Real-Time PCR System
(Applied Biosystems, Carlsbad, CA) [5]. Expression level was
normalized against endogenous 18 s for miR-375. Triplicate
independent experiments were performed.
Statistical Analysis
Statistical analysis was performed using Statistical Package for
Social Sciences (SPSS) 16.0 for Windows (SPSS Inc., Chicago, IL,
USA). x2-test or Fisher’s exact test was used to analyze the
association of miR-375 expression and clinicopathological param-
eters. The survival curves were plotted by using Kaplan-Meier
analysis. Differences were considered significant when p value was
less than 0.05.
Figure 3. Validation of MISH results by RT-PCR. (A) Expression of miR375 was detected in a series of cell lines by MISH (1,0006magnification).
The result showed that miR375 expression level was consistent with data derived from RT-PCR (B).
doi:10.1371/journal.pone.0053582.g003
miR-375 in ESCC
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Results
Detection of miRNA Expression in Cell Lines and Tissue
Sections
To explore whether the MISH is a useful tool in miRNA
detection, MISH was applied to study expression of miR-146b-5p
in lung cancer cell lines and cancer tissues. In lung cancer cell line
SCC211441, the fluorescence signals of miR-146b-5p probe
(green color) were dispersed uniformly throughout the cytoplasm
of tumor cells (Fig. 1A, right panel). Interestingly, no miR-146b-5p
signals were observed in a few of the cells (Fig. 1A, indicated by an
arrow). No specific signals could be detected in cells hybridized
with scramble probe (Fig. 1A, left panel). In lung cancer tissue
sections, overexpression of miR-146b-5p could be only detected in
tumor tissue (Fig. 1B, right panel) but not in non-tumor tissue
(Fig. 1B, left panel). Similar results could be observed in MISH
with miR-375 probe in ESCC cell line and tissue section. In ESCC
cell line KYSE510, expression of miR-375 could be detected by
MISH with specific probe (Fig. 2A, right panel), but not by
scramble probe (Fig. 2A, left panel). In ESCC tissue sections,
strong expression of miR-375 could be detected in non-tumor
tissue (Fig. 2B, left panel), but not in tumor tissue (Fig. 2B, right
panel).
Validation of MISH Results with QRT-PCR
To validate the accuracy of the MISH, QRT-PCR was
performed in multiple cell lines and the results were compared
to the MISH results. The expression level of miR-375 was varied
in different cell lines and high-level expression was detected in
SCC212102, KYSE140, KYSE510 and SCC211441 (Fig. 3A).
Consistent with MISH data, expression level of miR-375 was also
higher in these cell lines (Fig. 3B), suggesting that MISH assay
could accurately reflect the expression level of a tested miRNA.
MiR-375 was Frequently Downregulated in ESCCs
In our previous study, we have demonstrated that miR-375 was
frequently downregulated in ESCCs, which was significantly
associated with advanced clinical stage, metastasis and poorer
Figure 4. Detection of miR-375 expression in ESCCs by MISH using TMA. Representative images of MISH in one pair of ESCC (tumor vs non-
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outcome of ESCC [5]. Here, we applied MISH to study the
clinical significance of miR-375 downregulation in 300 pairs of
primary ESCCs and corresponding non-tumor tissues using tissue
microarray (TMA). Informative results were obtained from 249
pairs of ESCC cases. Non-informative samples included lost
samples and samples with too few cells. MISH result showed that
downregulation of miR-375 could be detected in 135/249 (54.2%)
of informative ESCC tissues compared with their corresponding
non-tumor tissues (Fig. 4). To validate our MISH results, qRT-
PCR was used to compare expression levels of miR-375 between
tumor and their corresponding non-tumor tissues in 10 randomly
selected ESCCs (including 5 cases with downregulation of miR-
375). The results showed that downregulation and normal
expression of miR-375 was detected in 4/5 and 4/5 cases,
respectively. This data suggests that MISH result is consistent with
qRT-PCR result.
Downregulation of miR-375 is Associated with Poor
Outcome of ESCC
Clinical association study was applied to analyze the correlation
of miR-375 downregulation with ESCC clinicopathological
features using the SPSS 16.0 software. Downregulation of miR-
375 was defined when its fluorescent signals in tumor tissue was
obviously less and weaker than that in its corresponding non-
tumor tissue. As shown in table 1, the low expression of miR-375
was significantly correlated with lymph node metastasis (p = 0.04)
and advanced clinical stage (p = 0.003). Kaplan-Meier analysis was
performed to further investigate the prognostic significance of
miR-375 in ESCC. The result showed that downregulation of
miR-375 was significantly associated with poorer overall survival
rate in ESCC (Fig. 5).
Discussion
Many miRNAs have been reported to serve as biomarkers to
predict the overall survival of cancer patients, for example, miR-
146b-5p has been applied to estimate the survival of lung cancer
patients [8]. However, the methods of detecting miRNA, such as
RT-PCR or northern blot assays, cannot accurately detect
miRNA expression or localization in individual cell or in archival
tissue specimens. This technical limitation has limited miRNA
study. In studying correlation between a given miRNA and cancer
microenvironment, for example, we need to distinguish miRNA
expression levels in various cell types, such as fibroblasts,
immunocytes or cancer cells. To fulfill this increasing demand,
we developed a MISH approach to detect miRNA expression in
both cell lines and cancer tissue sections. Previous study by Neely
et al has found that fluorescent locked nucleic acid (LNA) probe,
which increased the stability of binding to the target miRNA,
could be used to detect expression level of miRNA [14]. Similarly,
our study found that the 2-F modified probes could also increase
the miRNA binding stability. Combining 29-F RNA and ELF
signal amplification technologies, we found MISH is able to
provide strong and specific signals for evaluating the expression
level and distribution of the tested miRNA in both cultured cells
and archival tissue specimens.
Several approaches have been used to quantify miRNA
expression. For example, fluorescent-labeled LNA probe has been
applied to quantify the expression profile of various miRNAs [15].
Another study combines LNA probes with enzyme-labeled
fluorescence to detect average miRNA copy number per cell
[16]. LNA probe with fluorescence in situ hybridization has been
also used to detect miRNAs expression in frozen tissue sections
Table 1. Clinical correlation of miR-375 expression in 249 of
primary ESCCs.
Clinical Feature Number miR-375 expression P value
Low Normal
Gender 0.308
Male 136 78(57.4%) 58(42.6%)
Female 113 57(50.4%) 56(49.6%)
Age 0.609
#60 105 59(56.2%) 46(43.8%)
.60 144 76(52.8%) 68(47.2%)
Tumor size (cm3)a, b 0.295
,10 57 29 (50.9%) 28 (49.1%)
10–20 71 44 (62.0%) 27 (38.0%)
.20 66 33 (50.0%) 33 (50.0%)
Tumor invasionc 0.257
T1 19 7 (36.8%) 12 (63.2%)
T2 73 39 (53.4%) 34 (46.6%)
T3 157 89 (56.7%) 68 (43.3%)
Lymph node Metastasis 0.040
N0 141 68 (48.2%) 73(51.8%)
N1 108 67 (62.0%) 41 (38.0%)
TNM stage 0.003
I–II 166 79 (47.6%) 87 (52.4%)
III–IV 83 56 (67.5%) 27 (32.5%)
aTumor size was measured and obtained by 0.56the length6(the wide)2.
bPartial data is not available, and the all statistic was based on the informative
data.
cInvasion was defined by results on final pathological analysis.
doi:10.1371/journal.pone.0053582.t001
Figure 5. Kaplan-Meier analysis shows that downregulation of
miR-375 expression was significantly associated with poor
overall survival in the ESCC (p=0.040, Log-rank test).
doi:10.1371/journal.pone.0053582.g005
miR-375 in ESCC
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[17]. In the present study, we demonstrated that MISH could be
applied to evaluate miRNA expression level in paraffin-embedded
archival tissue specimens, which makes large-scale study possible
using TMA.
To demonstrate MISH can be explored to investigate miRNA
expression in a high-throughput way, expression of miR-375 was
detected in ESCC using a TMA containing 300 primary ESCC
cases. The result indicates that MISH is a reliable approach to
study miRNA expression in paraffin-embedded sections. Although
MISH cannot quantify miRNA expression in individual cells, it is
able to distinguish miRNA expression between tumor and
surrounding non-tumor cells. In this study, informative miR-375
expression was detected in 249/300 (83%) of ESCC cases. Non-
informative specimens were mainly caused by the samples loss.
MISH result found that miR-375 was downregualted in 54.2% of
ESCC tumor tissues compared with their paired non-tumor
tissues. Clinical correlation study indicated that downregulation of
miR-375 was significantly associated with lymph node metastasis
(p = 0.04), advanced clinical stage (p = 0.003) and poor outcome
(p = 0.04) in patients with ESCC. Multivariate COX analyses
showed that miR-375 was not an independent risk factor for
overall patient survival. These data demonstrate that MISH is a
useful tool to evaluate miRNA status in a large-scale of samples by
testing miRNA expression in paraffin sections. In addition, this
approach may be also used to detect miRNA level in a single cell
in blood and other body fluids. Further studies will be needed to
develop this potential application of MISH assay.
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